FOXP3 and neoplasm: Considering that Tregs within the tumor microenvironment might significantly suppress local antitumor immune responses [21], increased presence of Foxp3+ T cells in peripheral blood or tumor tissues have been associated with negative prognoses for various cancers [22–24].